Kronos Bio Inc KRON:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:11 AM EDT
1.05quote price arrow up+0.02 (+1.94%)
Volume
38,066
52 week range
0.73 - 2.29
Loading...
  • Open1.04
  • Day High1.05
  • Day Low1.02
  • Prev Close1.03
  • 52 Week High2.29
  • 52 Week High Date07/13/23
  • 52 Week Low0.73
  • 52 Week Low Date11/14/23

Key Stats

  • Market Cap63.10M
  • Shares Out60.10M
  • 10 Day Average Volume0.80M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-16.8

KEY STATS

  • Open1.04
  • Day High1.05
  • Day Low1.02
  • Prev Close1.03
  • 52 Week High2.29
  • 52 Week High Date07/13/23
  • 52 Week Low0.73
  • 52 Week Low Date11/14/23
  • Market Cap63.10M
  • Shares Out60.10M
  • 10 Day Average Volume0.80M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-16.8

RATIOS/PROFITABILITY

  • EPS (TTM)-1.95
  • P/E (TTM)-0.54
  • Fwd P/E (NTM)-0.68
  • EBITDA (TTM)-116.742M
  • ROE (TTM)-55.84%
  • Revenue (TTM)6.288M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,791.87%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kronos Bio Inc

 

Profile

MORE
Kronos Bio, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics that target the deregulated transcription that causes cancer and other serious diseases. It is developing KB-0742, its internally discovered oral cyclin dependent kinase 9 (CDK9) inhibitor, for the treatment of MYC-amplified and others transcriptionally addicted solid tumors. It has initiated the Phase 2 portion of its Phase 1/2 clinical trial for KB-0742. It is also developing...
Arie Belldegrun M.D.
Non-Executive Independent Chairman of the Board
Norbert Bischofberger Ph.D.
President, Chief Executive Officer, Director
Sandra Gardiner
Interim Chief Financial Officer
Address
1300 S. El Camino Real, Suite 400
San Mateo, CA
94402
United States

Top Peers

SYMBOLLASTCHG%CHG
KZR
Kezar Life Sciences Inc
0.84+0.0015+0.1789%
CUE
Cue Biopharma Inc
1.87-0.03-1.84%
LVTX
LAVA Therapeutics NV
3.04+0.07+2.36%
MNOV
MediciNova Inc
1.35+0.06+4.65%
BLRX
BioLine RX Ltd
0.6534-0.0187-2.7823%